An Approach to Address the Need for Adolescent Opioid Stabilization and Treatment

Jonathan D. Avery, MD^b; John H. Mahlstedt, MD^a,b,*; Megan M. Mroczkowski, MD^c

Prim Care Companion CNS Disord 2023;25(2):22br03441

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (7)

Drug overdose deaths - health, United States. Centers for Disease Control and Prevention. Accessed January 21, 2022. https://www.cdc.gov/nchs/hus/topics/drug-overdose-deaths.htm
American Medical Association. Issue brief: nation’s drug-related overdose and death epidemic continues to worsen. Accessed January 21, 2022. https://www.ama-assn.org/system/files/issue-brief-increases-in-opioid-related-overdose.pdf
Friedman J, Godvin M, Shover CL, et al. Trends in drug overdose deaths among US adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398–1400. PubMed CrossRef
Johnston LD, Miech RA, O’Malley PM, et al. Monitoring the future National Survey results on drug use, 1975–2019: overview, key findings on adolescent drug use. ED.gov website. Accessed January 21, 2022. https://eric.ed.gov/?id=ED611736
Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. PubMed CrossRef
Hadland SE, Wharam JF, Schuster MA, et al. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171(8):747–755. PubMed CrossRef
Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259. PubMed CrossRef